ROCKVILLE, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced the launch of ExPERT DTx™, a new high throughput transfection platform for research and drug discovery applications. This modular, 96-well electroporation system enables labs to transfect primary cells and cell lines with minimal ce ...

CLEARWATER, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- NAPC Defense, Inc. (OTCID: BLIS) (“NAPC Defense” or “the Company”), a U.S. licensed defense manufacturer with exclusive rights to produce and distribute the CornerShot USA system, announced today that it has received $38,166,873.04 in new and recently finalized U.S. government task orders through its strategic partner Obera LLC (“Obera”) under existing U.S. Department of Defense and Department of State contract vehicles, with performance extending into the ...

Core Insights - Kraig Biocraft Laboratories (OTCQB: KBLB) is featured on the cover of the March issue of National Geographic, highlighting a significant scientific breakthrough in the production of spider silk, a material known for its exceptional strength and toughness [1][8]. Company Overview - Kraig Biocraft Laboratories is a biotechnology company focused on developing and commercializing spider silk-based fiber technologies, utilizing genetically engineered silkworms to produce high-performance, cost-effective, and scalable spider silk materials for various applications [10]. Scientific Breakthrough - The article titled "Unlocking Nature's Miracle" discusses the global effort to manufacture spider silk, emphasizing the transition of spider silk from a laboratory curiosity to a scalable biomaterial [1][3]. - Spider silk's extraordinary properties are attributed to specialized proteins called spidroins, which form fibers with unmatched tensile strength, elasticity, and toughness [4]. Production Method - The company has developed genetically engineered silkworm strains that can produce recombinant spider silk proteins, leveraging the silkworm's natural spinning system to create a viable production method [5][6]. - This production method is positioned alongside other international efforts, including fermentation-driven systems, providing a comprehensive overview of the advancements in the field [6]. Market Relevance - The March issue of National Geographic serves as a significant resource for readers interested in advanced materials, synthetic biology, and sustainable fibers, marking a growing mainstream interest in the field of recombinant biomaterials [7][8].

CORAL GABLES, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming Barclays 28th Annual Global Healthcare Conference on ...

PITTSBURGH, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the TD Cowen 46th Annual Health Care Conference on March 3, 2026, in Boston. Company executives will take part in a fireside chat scheduled at 3:10 pm ET and host investor meetings throughout the day. A webcast of the presentation will be available here beginning at 3:10 pm ET on Tuesday, March 3, 2026 and will be posted on the Investors section of the Compa ...

GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing. Attendees will also have the opportunity to participate in one-on-one meetings with ...

HAUPPAUGE, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGR, AMPGZ) today announced that its previously listed warrants (Nasdaq: AMPGW) expired in accordance with their original terms at 5:00 p.m. Eastern Time on February 19, 2026. Trading in the warrants ceased at the close of market on February 18, 2026, after which the warrants were removed from listing on Nasdaq. The Company reports that prior to their expiration, there were a total of 1,371,428 warrants outstanding wit ...

BRISBANE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president and chief executive officer, will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026 at 9:50 a.m. ET. A live webcast of the event can be accessed under the ‘Events & ...

OAK BROOK, Ill., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO), the one-of-a-kind restaurant concept known for its menu of Chicago-style favorites, today reported financial results for the fourth quarter and fiscal year ended December 28, 2025. Fourth Quarter 2025 Performance Highlights (vs. Fourth Quarter 2024): Total revenue of $185.7 million, an increase of 0.6% or $1.1 millionSame-restaurant sales decrease of -3.3%Operating income of $10.3 million, a de ...

CONSHOHOCKEN, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026 at 2:30 P.M. ET. The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events page. A replay of the webcast will be available after the event. About Madrigal PharmaceuticalsMadrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharm ...